MedTrace Logo

Validity of Scales to Assess Severity in Acute Heart Failure

NCT02437058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1854

Last updated 2020-07-13

No results posted yet for this study

Summary

The scales measuring the severity of acute decompensate heart failure (ADHF) in emergency departments have not achieved an adequate discriminative ability for decision making. Objectives: 1) Identify baseline variables, and evolutionary variables that may provide a good predictive ability of the model.2) Create and validate clinical predictive rules of mortality during admission/a week after ED visit in those discharged from ED, 30 and 60 days after ED visit as well as identify predicitive factors of short-term readmission (90 days)Design: Prospective cohort study. The sociodemographics and clinical variables will be collected from emergency medical records to identify predictors. Outcome variables and evolution of variables will be collected from hospital medical records / ambulatory during admission and up to 90 days after the episode of ADHF. Baseline predictors and evolutionary variables will be identified through logistic regression models using 60% of the final sample. The models that best fit will be applied in 40% of the sample to assess the predictive validity of this scale.

Conditions

Interventions

OTHER

preidictive model

Sponsors & Collaborators

  • Hospital Donostia

    collaborator OTHER

  • Hospital de Basurto

    collaborator OTHER

  • Hospital Galdakao-Usansolo

    lead OTHER_GOV

Principal Investigators

  • Jose María Quintana, PhD · Chief of Research unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-04-30
Completion
2015-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437058 on ClinicalTrials.gov